Mirum Pharmaceuticals, Inc. MIRM Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s return on equity?
- Mirum Pharmaceuticals, Inc. (MIRM) reported return on equity of -335.8% in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s return on equity changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s return on equity decreased by 915.8% year-over-year, from -33.1% to -335.8%.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s return on equity?
- Over 4 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s return on equity has grown at a -40.3% compound annual growth rate (CAGR), from -68.3% to -8.6%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.